Skip to content
Catalyst

PapersPMID:27320846

The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial.

Scientific reports2016The record ↗

  1. Finding, limited evidencelowersTumour necrosis factor alpha concentration

What moved

1 findingHow to read these marks →
  • “However, the addition of GTP to the existing treatment regimen significantly reduced mean serum DKK-1 (p = 0.004) and tumor necrosis factor alpha (TNF-α; p = 0.003) with no significant change in urinary 8-isoprostane concentrations (Table 3).”
    Study
    RCT
    Duration
    3 months
    Dose studied
    four capsules daily of green tea polyphenols (TP98) corresponding to 800 mg EGCG
    Population
    Adults with type 1 or type 2 diabetes and persistent albuminuria (UACR over 30 mg/g) despite maximum-dose ACE inhibitor or ARB treatment, which both arms continued; 21 completed in each arm

Study record

Design
randomised controlled trial
Species
human / mixed
Population
42 adults with type 1 or type 2 diabetes and persistent albuminuria (UACR over 30 mg/g) despite maximum doses of ACE inhibitors and/or ARBs; green tea polyphenols (800 mg EGCG/day) vs placebo; plus in vitro immortalized human podocyte experiments with patient plasma and EGCG
Participants
42
Comparator
placebo
Duration
84 days
Endpoints measured
20
Declined
the intervention held more than the compound